Canada markets closed


Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.00350.0000 (0.00%)
At close: 09:07AM CEST
Full screen
Previous Close0.0035
Bid0.0035 x 0
Ask0.0060 x 0
Day's Range0.0030 - 0.0030
52 Week Range0.0010 - 0.0120
Avg. Volume14,086
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    Xeris Biopharma to Report First Quarter 2022 Financial Results on May 11, 2022

    CHICAGO, May 04, 2022--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology, today announced that the Company will release its first quarter 2022 financial results before the open of the U.S. financial markets on Wednesday, May 11, 2022. Management will host a conference call and webcast at 8:30 a.m. Eastern Time that day to discuss the Company’s financi